|
|||||
|
|
Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials |
|
| Abstract: | |
| Keywords: | CLL FCR relapse salvage therapy toxicity |
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
|
|
|
| 设为首页 | 免责声明 | 关于勤云 | 加入收藏 |
|
Copyright©北京勤云科技发展有限公司 京ICP备09084417号 |